Crispen P - Search Results

1

High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.

Raman JD, Lin YK, Kaag M, Atkinson T, Crispen P, Wille M, Smith N, Hockenberry M, Guzzo T, Peyronnet B, Bensalah K, Simhan J, Kutikov A, Cha E, Herman M, Scherr D, Shariat SF, Boorjian SA. Raman JD, et al. Among authors: crispen p. Urol Oncol. 2014 Jan;32(1):47.e9-14. doi: 10.1016/j.urolonc.2013.06.015. Epub 2013 Oct 17. Urol Oncol. 2014. PMID: 24140248

2

Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.

Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. Boorjian SA, et al. J Urol. 2008 Jul;180(1):99-103; discussion 103. doi: 10.1016/j.juro.2008.03.025. Epub 2008 May 15. J Urol. 2008. PMID: 18485415

3

The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.

Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. Boorjian SA, et al. Eur Urol. 2008 Oct;54(4):855-63. doi: 10.1016/j.eururo.2008.04.079. Epub 2008 May 9. Eur Urol. 2008. PMID: 18487007

4

Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.

Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Crispen PL, et al. Cancer. 2008 Aug 1;113(3):450-60. doi: 10.1002/cncr.23566. Cancer. 2008. PMID: 18523999 Free PMC article. Review.

5

Outcomes following partial nephrectomy by tumor size.

Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC. Crispen PL, et al. J Urol. 2008 Nov;180(5):1912-7. doi: 10.1016/j.juro.2008.07.047. Epub 2008 Sep 17. J Urol. 2008. PMID: 18801543

6

Radiation therapy after radical prostatectomy: impact on metastasis and survival.

Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Blute ML. Boorjian SA, et al. J Urol. 2009 Dec;182(6):2708-14. doi: 10.1016/j.juro.2009.08.027. J Urol. 2009. PMID: 19836762

7

Functional and oncological outcomes after orthotopic neobladder reconstruction in women.

Granberg CF, Boorjian SA, Crispen PL, Tollefson MK, Farmer SA, Frank I, Blute ML. Granberg CF, et al. BJU Int. 2008 Dec;102(11):1551-5. doi: 10.1111/j.1464-410X.2008.07909.x. Epub 2008 Oct 8. BJU Int. 2008. PMID: 18990170

8

The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Sebo TJ, Blute ML. Boorjian SA, et al. J Urol. 2009 Jan;181(1):95-104; discussion 104. doi: 10.1016/j.juro.2008.09.016. Epub 2008 Nov 13. J Urol. 2009. PMID: 19012937

9

Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.

Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG. Crispen PL, et al. Cancer. 2009 Jul 1;115(13):2844-52. doi: 10.1002/cncr.24338. Cancer. 2009. PMID: 19402168 Free PMC article.

10

The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era.

Boorjian SA, Karnes RJ, Crispen PL, Carlson RE, Rangel LJ, Bergstralh EJ, Blute ML. Boorjian SA, et al. J Urol. 2010 Mar;183(3):1003-9. doi: 10.1016/j.juro.2009.11.039. Epub 2010 Jan 21. J Urol. 2010. PMID: 20092854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page